218 related articles for article (PubMed ID: 18327394)
21. Effects of microgravity and hypergravity on platelet functions.
Dai K; Wang Y; Yan R; Shi Q; Wang Z; Yuan Y; Cheng H; Li S; Fan Y; Zhuang F
Thromb Haemost; 2009 May; 101(5):902-10. PubMed ID: 19404544
[TBL] [Abstract][Full Text] [Related]
22. Surface-dependent expression in the platelet GPIb binding domain within human von Willebrand factor studied by atomic force microscopy.
Kang I; Raghavachari M; Hofmann CM; Marchant RE
Thromb Res; 2007; 119(6):731-40. PubMed ID: 17010412
[TBL] [Abstract][Full Text] [Related]
23. Enhancing effect of the (145)Met-allele of GPIb alpha on platelet sensitivity to aspirin under high-shear conditions.
Matsubara Y; Murata M; Watanabe G; Ikeda Y
Thromb Res; 2008; 123(2):331-5. PubMed ID: 18417193
[No Abstract] [Full Text] [Related]
24. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
McNicol A; Eyer E; Jackson EC; Israels SJ
Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
[No Abstract] [Full Text] [Related]
25. Antithrombotic Effects of Paeoniflorin from
Ngo T; Kim K; Bian Y; Noh H; Lim KM; Chung JH; Bae ON
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614534
[TBL] [Abstract][Full Text] [Related]
26. Synergic effect of
Li D; Zhang X; Zhang H; Li X
Vascular; 2020 Jun; 28(3):309-313. PubMed ID: 31902309
[TBL] [Abstract][Full Text] [Related]
27. Mouse models to study von Willebrand factor structure-function relationships in vivo.
Denis CV; Marx I; Badirou I; Pendu R; Christophe O
Hamostaseologie; 2009 Jan; 29(1):17-8, 20. PubMed ID: 19151840
[TBL] [Abstract][Full Text] [Related]
28. A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene.
Nurden P; Lanza F; Bonnafous-Faurie C; Nurden A
Thromb Haemost; 2007 Feb; 97(2):319-21. PubMed ID: 17264965
[No Abstract] [Full Text] [Related]
29. Primary platelet adhesion receptors.
Yip J; Shen Y; Berndt MC; Andrews RK
IUBMB Life; 2005 Feb; 57(2):103-8. PubMed ID: 16036569
[TBL] [Abstract][Full Text] [Related]
30. The search for new antithrombotic mechanisms and therapies that may spare hemostasis.
Plow EF; Wang Y; Simon DI
Blood; 2018 Apr; 131(17):1899-1902. PubMed ID: 29467183
[TBL] [Abstract][Full Text] [Related]
31. The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons.
Fontayne A; Meiring M; Lamprecht S; Roodt J; Demarsin E; Barbeaux P; Deckmyn H
Thromb Haemost; 2008 Oct; 100(4):670-7. PubMed ID: 18841291
[TBL] [Abstract][Full Text] [Related]
32. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation.
McEver RP
Thromb Haemost; 2001 Sep; 86(3):746-56. PubMed ID: 11583304
[No Abstract] [Full Text] [Related]
33. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
[TBL] [Abstract][Full Text] [Related]
34. The interaction of thrombin with blood platelets.
Lundblad RL; White GC
Platelets; 2005 Nov; 16(7):373-85. PubMed ID: 16236598
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
36. Platelet function and arterial thrombosis.
Ruggeri ZM; Landolfi R
Ital Heart J; 2001 Nov; 2(11):809-10. PubMed ID: 11770863
[No Abstract] [Full Text] [Related]
37. Experimental animal models of arterial thrombosis and the screening of platelet-inhibiting, anti-thrombotic drugs: a review.
Philp RB
Methods Find Exp Clin Pharmacol; 1979 Oct; 1(4):197-224. PubMed ID: 399655
[No Abstract] [Full Text] [Related]
38. Synergistic effect of aurintricarboxylic acid and triflavin in a photochemically induced thrombosis model in rats.
Hisamichi N; Kawasaki T; Suzuki K; Kaku S; Sakai Y; Taniuchi Y; Sato K; Inagaki O; Tomioka K; Yanagisawa I; Takenaka T; Yanagi K; Ohshima N
Eur J Pharmacol; 1996 Sep; 312(1):69-73. PubMed ID: 8891580
[TBL] [Abstract][Full Text] [Related]
39. Anti-thrombotic effects of selective estrogen receptor modulator tamoxifen.
Nayak MK; Singh SK; Roy A; Prakash V; Kumar A; Dash D
Thromb Haemost; 2011 Oct; 106(4):624-35. PubMed ID: 21866300
[TBL] [Abstract][Full Text] [Related]
40. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
Franchini M; Montagnana M; Lippi G
Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
